Tag Archives: AI for drug discovery

September 29, 2020
In The News

[Nature] Artificial intelligence (A.I.) is expected to significantly influence the practice of medicine and the delivery of healthcare in the near future. While there are only a handful of practical examples for its medical use with enough evidence, hype and attention around the topic are significant. There are so many papers, conference talks, misleading news […]

Read Article
September 9, 2020
In The News

[BioSpace]  Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today a partnership with GC Pharma (KRX: 006280), a South Korean biopharmaceutical company formerly known as Green Cross Corporation, to discover and develop novel hemophilia therapies. GC Pharma is a pioneer in vaccines and protein therapeutics and has long been dedicated to […]

Read Article
August 24, 2020
In The News

[Outsourcing-Pharma] The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery

Read Article
August 19, 2020
In The News

[Drug Target Review] According to a new report, artificial intelligence (AI) is vital for the rapid identification of drugs that can be repurposed to combat COVID-19.

Read Article
August 11, 2020
In The News

[VentureBeat] Atomwise, a startup using AI to accelerate drug discovery, today secured $123 million in funding. A spokesperson said the funds will enable the startup to scale its technology and team as it expands its portfolio of joint ventures with researchers at the University of Toronto, Duke University School of Medicine, Charles River, Bayer, Eli Lilly, […]

Read Article
August 11, 2020
In The News

[San Francisco Business Times] As several companies emerge with the label of AI drug discovery, this San Francisco company has hundreds of projects and now a big funding round.

Read Article